Fatal enhanced respiratory syncytial virus disease in toddlers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fatal enhanced respiratory syncytial virus disease in toddlers

Published:2021-10-20 Issue:616 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Polack Fernando P.¹²^ORCID,Alvarez-Paggi Damián¹³^ORCID,Libster Romina¹³,Caballero Mauricio T.¹³^ORCID,Blair Robert V.⁴^ORCID,Hijano Diego R.¹⁵^ORCID,de la Iglesia Niveyro Paola X.⁶,Menendez Daniel R.⁷^ORCID,Gladwell Wes⁷,Avendano Luis M.⁸,Velozo Luis⁸,Wanek Alanna⁴,Bergel Eduardo⁹^ORCID,Prince Gregory A.¹⁰,Kleeberger Steven R.⁶^ORCID,Johnson Joyce²^ORCID,Pociask Derek⁴,Kolls Jay K.⁴^ORCID

Affiliation:

1. Fundación INFANT, Buenos Aires, Argentina.

2. Vanderbilt University, Nashville, TN, USA.

3. National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.

4. Tulane University, New Orleans, LO, USA.

5. St. Jude Children’s Research Hospital, Memphis, TN, USA.

6. Hospital Italiano de Buenos Aires Argentina, Buenos Aires, Argentina.

7. National Institute of Environmental Health Sciences (NIEHS), Raleigh, NC, USA.

8. Universidad Nacional de Chile, Santiago, Chile.

9. Instituto de Efectividad Clinica y Sanitaria, Buenos Aires, Argentina.

10. Independent Researcher, Potomac, MD, USA.

Abstract

Fatal enhanced respiratory syncytial virus disease in toddlers has distinctive immune and transcriptional features.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference24 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

2. Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

3. A proof of concept for structure-based vaccine design targeting RSV in humans

4. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

5. RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral Intranasal Nanovaccines as Antivirals for Respiratory Syncytial Virus;Advanced Materials;2024-09-02

2. Eosinophils as modulators of host defense during parasitic, fungal, bacterial, and viral infections;Journal of Leukocyte Biology;2024-08-13

3. Characterization of bronchiolitis and vaccine-induced enhanced respiratory disease in Syrian hamsters caused by respiratory syncytial virus infection;2024-07-30

4. Immune Responses and Protection Profiles in Mice Induced by Subunit Vaccine Candidates Based on the Extracellular Domain Antigen of Respiratory Syncytial Virus G Protein Combined with Different Adjuvants;Vaccines;2024-06-19

5. Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody Against RSV Bronchiolitis Virus): Mixed Results, Identification of Biases, and Possible Role and Mechanisms of ADE (Antibody Dependent Enhancement);2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3